ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,422Medicare Part D Prescriptions Filled, Including Refills

Rank: 166 out of 1448

$566K Total Retail Price of All Prescriptions

Rank: 102 out of 1448

142 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

54% of this provider’s 142 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

1% of this provider’s 4,983 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

43% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$88 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
ACETAMINOPHEN-CODEINE 544 406 S3 1 113
AMLODIPINE BESYLATE-BENAZEPRIL 533 403 2 67
CRESTOR 346 258 3 17
TRAMADOL HCL-ACETAMINOPHEN 218 187 4 202
TRAMADOL HCL 218 132 4 56
ZOLPIDEM TARTRATE 180 147 6 34
SPIRIVA 172 127 7 97
NEXIUM 151 105 8 49
ACTOPLUS MET 150 119 9 237
COREG CR 147 124 10 83
VOLTAREN 134 112 11 107
GLIMEPIRIDE 129 81 12 66
ADVAIR HFA 128 78 13 245
ISOSORBIDE MONONITRATE ER 123 111 14 16
CARVEDILOL 118 102 15 1
FUROSEMIDE 116 101 16 7
CLOPIDOGREL 97 92 17 10
ADVAIR DISKUS 91 63 18 74
ZETIA 90 78 19 28
SPIRONOLACTONE 85 70 20 24
AZOR 84 84 21 125
PLAVIX 78 75 22 14
COMBIVENT 77 61 23 147
PRAVASTATIN SODIUM 77 66 23 20
IBUPROFEN 76 46 25 85
OMEPRAZOLE 74 35 26 23
DONEPEZIL HCL 72 72 27 68
DETROL LA 68 53 28 236
GABAPENTIN 66 58 29 51
NITROSTAT 63 54 30 31
LOSARTAN-HYDROCHLOROTHIAZIDE 54 53 31 38
ATORVASTATIN CALCIUM 54 42 31 4
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.